1 Updates
New therapy for breast cancer
Photo Credit: Streeter Lecka, Getty Images

New therapy for breast cancer

Feb 23 2013, 4:08am CST | by

Washington, Feb 23 (IANS) Breast cancer patients will now have an effective and less toxic therapeutic option.

Washington, Feb 23 — Breast cancer patients will now have an effective and less toxic therapeutic option. The Food and Drug Administration (FDA) has given the go-ahead to a new drug therapy for...

Filed under: news

Full Story below YouTube Videos

 
 

 

1 year ago

New therapy for breast cancer

Feb 23 2013, 4:08am CST | by

Washington, Feb 23 (IANS) Breast cancer patients will now have an effective and less toxic therapeutic option.

Washington, Feb 23 — Breast cancer patients will now have an effective and less toxic therapeutic option.

The Food and Drug Administration (FDA) has given the go-ahead to a new drug therapy for patients with HER2-positive - particularly aggressive form of breast cancer.

On Friday, the Food and Drug Administration (FDA) approved the new treatment drug, Kadcyla (trastuzumab emtansine), also known as TDM-1, which combines Traztuzumab, also called Herceptin, with the powerful chemotherapy drug emtansine.

The drug therapy is developed by Roche-owned Genentech, which funded the study.

Results from clinical trials of the drug TDM-1, known as "Super Herceptin," showed that it was more effective and less toxic than the standard regimen for this type of tumour.

The medication kept patients free of disease for longer than the standard chemotherapy regimen.

HER-2 positive breast cancer patients have been found to be positive for carrying a protein that promotes the growth of cancer cells.

TDM-1 is taken directly to cells that have the HER2 protein on the membrane, such as the cancer cells, while sparing normal cells. This results in less toxicity from the chemotherapy drug, reports Science Daily.

"TDM-1 works like the original drug Herceptin by hunting down and interfering with the cancer cells," said Melody Cobleigh, director of the Comprehensive Breast Centre at Rush centre, Illinois and lead investigator of the TDM-1 clinical trials at Rush.

IANS

Source: IANS

 

Don't miss ...

 

<a href="/latest_stories/all/all/8" rel="author">Luigi Lugmayr</a>
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.

 

blog comments powered by Disqus

Latest stories

Solaire Shines Light On Philippine Casino Ambitions
The Philippines hopes to be the next big thing in Asian gaming, and its biggest step toward that goal just completed its first year of operation. Solaire Resort and Casino opened in March last year (see page 77; payment...
 
 
Innovators In The UK: Male, Affluent And Long-Term Planners
For decades, innovation policy has been the domain of technocrats and of party–political consensus. Whilst in other fields – such as science – regular surveys help inform public debate and policy-making, there has been...
 
 
Want To Earn $5,000? Stop Working
If you work for Amazon, Jeff Bezos will pay you a bonus of up to $5,000.  Generous, right?  And what do you have to do to get the bonus? Quit your job. It may seem crazy, but it’s true – a recent article in Time notes...
 
 
Your Local Mall, Re-digitized
As part of the never-ending battle for the consumer dollar, General Growth Properties, which owns some 120 high-end malls through the U.S., has recruited RetailMeNot to its side. Under a new agreement the two announced...
 
 
 

Latest from the Network

Aaron Sorkin Gives More Details On Jobs Movie
The upcoming Steve Jobs movie based on the Walter Isaacson biography is still in the works, with Aaron Sorkin in charge of writing the script. Unfortunately, that is almost all that we currently know about the film.He...
Read more on Apple Balla
 
Innovators In The UK: Male, Affluent And Long-Term Planners
For decades, innovation policy has been the domain of technocrats and of party–political consensus. Whilst in other fields – such as science – regular surveys help inform public debate and policy-making, there has been...
Read more on Business Balla
 
Cameron Diaz planning holiday for Gwyneth Paltrow
Cameron Diaz is organizing a girls' holiday to help Gwyneth Paltrow get over her marriage split. The 'Other Woman' actress is keen to cheer up her friend following the end of her 10-year marriage to Chris Martin and is...
Read more on Celebrity Balla
 
Want To Earn $5,000? Stop Working
If you work for Amazon, Jeff Bezos will pay you a bonus of up to $5,000.  Generous, right?  And what do you have to do to get the bonus? Quit your job. It may seem crazy, but it’s true – a recent article in Time notes...
Read more on Business Balla
 
Your Local Mall, Re-digitized
As part of the never-ending battle for the consumer dollar, General Growth Properties, which owns some 120 high-end malls through the U.S., has recruited RetailMeNot to its side. Under a new agreement the two announced...
Read more on Business Balla
 
Jon Hamm slams Justin Bieber
Jon Hamm has branded Justin Bieber a "sh**head." The 'Mad Men' star thinks the 20-year-old singer - who is facing charges for Driving Under the Influence (DUI), resisting arrest and possessing an invalid driver's...
Read more on Celebrity Balla
 
Can Urban WebSlams STEM The Dropout Tide?
On Saturday, April 12, twenty L.A. charter high school students received an opportunity not easily available to them during the regular school day. The mostly black and Hispanic cohort — who hailed from three of...
Read more on Business Balla
 
Are You Too Tentative? Four Ways To Take Smarter Risks, Not Just Safe Ones
When making decisions, most people like to think they are pretty good at weighing up the pros and cons and choosing the smartest course of action.  Unfortunately though, when it comes to assessing potential risks,  most...
Read more on Business Balla
 
Josh Hartnett regrets dating co-stars
Josh Hartnett has hinted he regrets dating Scarlett Johansson. The 35-year-old actor - who is currently in a relationship with British actress Tamsin Egerton - claims that romancing some of his former co-stars has had a...
Read more on Celebrity Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla